JP2022130637A5 - - Google Patents

Download PDF

Info

Publication number
JP2022130637A5
JP2022130637A5 JP2022105784A JP2022105784A JP2022130637A5 JP 2022130637 A5 JP2022130637 A5 JP 2022130637A5 JP 2022105784 A JP2022105784 A JP 2022105784A JP 2022105784 A JP2022105784 A JP 2022105784A JP 2022130637 A5 JP2022130637 A5 JP 2022130637A5
Authority
JP
Japan
Prior art keywords
antigen
immunogenic
nomv
immunogenic conjugate
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022105784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022130637A (ja
JP7439174B2 (ja
Filing date
Publication date
Priority claimed from GBGB1619946.5A external-priority patent/GB201619946D0/en
Priority claimed from GBGB1712096.5A external-priority patent/GB201712096D0/en
Priority claimed from PCT/EP2017/080145 external-priority patent/WO2018096007A2/en
Application filed filed Critical
Publication of JP2022130637A publication Critical patent/JP2022130637A/ja
Publication of JP2022130637A5 publication Critical patent/JP2022130637A5/ja
Application granted granted Critical
Publication of JP7439174B2 publication Critical patent/JP7439174B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022105784A 2016-11-25 2022-06-30 免疫原性コンジュゲート及びその使用 Active JP7439174B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB1619946.5 2016-11-25
GBGB1619946.5A GB201619946D0 (en) 2016-11-25 2016-11-25 Conjugated immunogenic derivatives and use thereof
GBGB1712096.5A GB201712096D0 (en) 2017-07-27 2017-07-27 Immunogenic conjugates and use thereof
GB1712096.5 2017-07-27
PCT/EP2017/080145 WO2018096007A2 (en) 2016-11-25 2017-11-23 Immunogenic conjugates and use thereof
JP2019527901A JP7100031B2 (ja) 2016-11-25 2017-11-23 免疫原性コンジュゲート及びその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019527901A Division JP7100031B2 (ja) 2016-11-25 2017-11-23 免疫原性コンジュゲート及びその使用

Publications (3)

Publication Number Publication Date
JP2022130637A JP2022130637A (ja) 2022-09-06
JP2022130637A5 true JP2022130637A5 (https=) 2022-09-30
JP7439174B2 JP7439174B2 (ja) 2024-02-27

Family

ID=60702606

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019527901A Active JP7100031B2 (ja) 2016-11-25 2017-11-23 免疫原性コンジュゲート及びその使用
JP2022105784A Active JP7439174B2 (ja) 2016-11-25 2022-06-30 免疫原性コンジュゲート及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019527901A Active JP7100031B2 (ja) 2016-11-25 2017-11-23 免疫原性コンジュゲート及びその使用

Country Status (9)

Country Link
US (1) US12036285B2 (https=)
EP (1) EP3544625A2 (https=)
JP (2) JP7100031B2 (https=)
CN (1) CN110214022A (https=)
BE (1) BE1025210B1 (https=)
BR (1) BR112019010227A2 (https=)
CA (1) CA3044569A1 (https=)
MX (1) MX2019006104A (https=)
WO (1) WO2018096007A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019010227A2 (pt) 2016-11-25 2019-10-08 Glaxosmithkline Biologicals S.A. conjugado imunogênico, processo para preparação de conjugado imunogênico, composição imunogênica, vacina, e, uso de nomv
JP7165468B2 (ja) * 2016-11-25 2022-11-04 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム nOMV-抗原コンジュゲート及びその使用
GB201712824D0 (en) * 2017-08-10 2017-09-27 Glaxosmithkline Biologicals Sa Multi-functionalized nOMV Conjugates
CN111358942A (zh) * 2018-12-25 2020-07-03 国家纳米科学中心 一种疫苗及其制备方法
JP7462864B2 (ja) * 2019-04-19 2024-04-08 国立感染症研究所長 メンブレンヴェシクル
US20220378902A1 (en) * 2019-08-22 2022-12-01 Sichuan University Bacterial membrane vesicles, and separation and preparation system and method therefor

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271147A (en) 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
NZ214503A (en) 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
US4707543A (en) 1985-09-17 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines
IE912559A1 (en) 1990-07-19 1992-01-29 Merck & Co Inc The class ii protein of the outer membrane of neisseria¹meningitidis, and vaccines containing same
CA2264970A1 (en) * 1998-03-10 1999-09-10 American Cyanamid Company Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria
JP2003518363A (ja) 1999-04-30 2003-06-10 カイロン エセ.ピー.アー. 保存されたナイセリア抗原
PL216780B1 (pl) 2000-01-25 2014-05-30 Univ Queensland Of Santa Lucia Wyizolowane białka zawierające konserwatywne obszary antygenu powierzchniowego NhhA z Neisseria meningitidis, białka fuzyjne, kompozycja farmaceutyczna, przeciwciało monoklonalne lub wiążący antygen fragment przeciwciała monoklonalnego, wyizolowany kwas nukleinowy, konstrukt ekspresyjny, komórka gospodarza, sposób wytwarzania rekombinowanego białka, sposób wykrywania N. meningitidis w próbce biologicznej, sposób diagnozowania zakażenia N. meningitidis oraz sposób wykrywania N. meningitidis w próbce biologicznej uzyskanej od pacjenta oraz zastosowanie wyizolowanego białka, białka fuzyjnego i konstruktu ekspresyjnego
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
WO2006124712A2 (en) 2005-05-16 2006-11-23 Merck & Co., Inc. A method for improving the immunogenicity of plasmodium antigens
GB2441094B (en) 2005-05-19 2010-11-03 Edward Jenner Inst For Vaccine Methods for treatment and prevention of infection
PT2729167T (pt) * 2011-07-07 2018-06-20 Vert Door De Mini Van Vws De Staat Der Nederlanden Um processo para a produção sem detergente de desículas de membrana externa de uma bactéria gram-negativa
WO2013174832A1 (en) 2012-05-22 2013-11-28 Novartis Ag Meningococcus serogroup x conjugate
EP2870974A1 (en) * 2013-11-08 2015-05-13 Novartis AG Salmonella conjugate vaccines
US20170326220A1 (en) 2014-11-28 2017-11-16 Janssen Vaccines & Prevention B.V. Meningitis b vaccine
EP3838918B1 (en) 2015-05-18 2022-08-31 BiOMVis Srl Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof
KR102026829B1 (ko) 2016-07-11 2019-10-01 보에 테크놀로지 그룹 컴퍼니 리미티드 칩 온 필름, 이를 갖는 플렉시블 디스플레이 장치, 및 그 제조 방법
JP7165468B2 (ja) 2016-11-25 2022-11-04 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム nOMV-抗原コンジュゲート及びその使用
BR112019010227A2 (pt) 2016-11-25 2019-10-08 Glaxosmithkline Biologicals S.A. conjugado imunogênico, processo para preparação de conjugado imunogênico, composição imunogênica, vacina, e, uso de nomv

Similar Documents

Publication Publication Date Title
JP2022130637A5 (https=)
JP7268125B2 (ja) コンジュゲート化莢膜糖類抗原を含む免疫原性組成物、それを含むキットおよびこれらの使用
US20240226261A9 (en) Vaccine
Trotter et al. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
TWI281403B (en) Vaccine
TWI789357B (zh) 多價肺炎球菌多醣-蛋白質共軛物組成物(二)
CN102869375B (zh) 包含与载体蛋白缀合的肺炎链球菌多糖的免疫原性组合物
JP2023036953A (ja) 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強
EA014165B1 (ru) Пневмококковая полисахаридная конъюгатная вакцина
TWI770044B (zh) 多價肺炎球菌多醣-蛋白質共軛物組成物(一)
BR112020014978A2 (pt) Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
RU2774891C2 (ru) Повышение иммуногенности конъюгатов полисахарид streptococcus pneumoniae-белок
CN121313812A (zh) 一种31价肺炎球菌荚膜多糖的组合物、含其的疫苗及其制备与应用
CN116898960A (zh) 细菌多糖蛋白缀合物及其应用